Wendys Co vs State Street SPDR S&P Biotech ETF — how do they compare? Wendys Co trades at $7.62 (market cap $1.50B), while State Street SPDR S&P Biotech ETF trades at $154.42. The key difference: Wendys Co pays a 7.13% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Wendys Co nearer its low. Which is the better fit depends on your goals.
| WEN | XBI | |
|---|---|---|
Market Cap | $1.50B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $11.33 | $164.28 |
52-Week Low | $6.17 | $85.16 |
Enterprise Value | $5.31B | — |
Dividend Yield | 7.13% | — |
Trailing returns across standard periods
Latest headlines on both assets
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →